LFA
BIIB icon

Livelsberger Financial Advisory’s Biogen BIIB Stock Holding History

Livelsberger Financial Advisory’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$12.6K – 16
2025
Q2 		$12.6K Buy
+100
New +$12.5K 0.24% 46
2024
Q4 		– Sell
-100
Closed -$19.4K – 15
2024
Q3 		$19.4K Buy
+100
New +$20.9K 0.41% 41
2024
Q1 		– Sell
-100
Closed -$25.9K – 33
2023
Q4 		$25.9K Buy
+100
New +$24.6K 0.02% 204

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Livelsberger Financial Advisory's BIIB Position: Q3 2025 in Review

Livelsberger Financial Advisory sold out of Biogen (BIIB) in Q3 2025, closing a stake of 100 shares — an estimated $12.6K sold.

Livelsberger Financial Advisory first reported a position in BIIB in Q4 2023 and held it in 3 quarters. The position peaked at $25.9K in Q4 2023. 906 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Livelsberger Financial Advisory reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Livelsberger Financial Advisory sold 100 Biogen shares in Q3 2025, an estimated $12.6K.
  • Livelsberger Financial Advisory first reported a position in Biogen in Q4 2023 and held it in 3 quarters.
  • Livelsberger Financial Advisory's Biogen position peaked at $25.9K in Q4 2023.
  • 906 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Livelsberger Financial Advisory's 13F filing for Q3 2025, filed 14 Oct 2025.